Evidence map›Paper›PMID 38843221›Full record

ArticlePloS one2024

One-year continuation of postpartum intrauterine contraceptive device: Findings from a prospective cohort study in India.

Ashish Srivastava, Surendra Sharma, Kamlesh Lalchandani, Nochiketa Mohanty, Deepak Chandra Bhatt, Gulnoza Usmanova, Bulbul Sood, Somesh Kumar

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ashish SrivastavaJhpiego-An Affiliate of Johns Hopkins University, New Delhi, India.
Surendra SharmaJhpiego-An Affiliate of Johns Hopkins University, Raipur, Chhattisgarh, India.
Kamlesh LalchandaniJhpiego-An Affiliate of Johns Hopkins University, New Delhi, India.
Nochiketa MohantyJhpiego-An Affiliate of Johns Hopkins University, Bhubaneshwar, Odisha, India.
Deepak Chandra BhattJhpiego-An Affiliate of Johns Hopkins University, New Delhi, India.ORCID 0000-0002-7421-6950
Gulnoza UsmanovaJhpiego-An Affiliate of Johns Hopkins University, New Delhi, India.
Bulbul SoodJhpiego-An Affiliate of Johns Hopkins University, New Delhi, India.
Somesh KumarJhpiego-An Affiliate of Johns Hopkins University, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

OBJECTIVE(S): To estimate continuation rates for postpartum intrauterine contraceptive device (PPIUD) at 6 weeks, 6 months and 1-year within existing programs in an under-resourced setting, and to identify determinants of discontinuation, removal and expulsion. STUDY

designWe used a prospective cohort design and enrolled recent PPIUD adopter women across 100 public healthcare facilities in Odisha and Chhattisgarh, India. We collected their socio-demographic information and followed them up telephonically at 6 weeks, 6 months and 1 year for complications and continuation status. We assessed PPIUD continuation rates and factors associated with PPIUD discontinuation, removal, and expulsion using Cox proportional hazards modelling.

resultsWe enrolled 916 participants (579 (63.2%) from Odisha and 337 (36.8%) from Chhattisgarh). The continuation rate of PPIUD was 88.7% at 6 weeks, 74.8% at 6 months 60.1% at one year. Once discontinued, chances of not opting for any family planning method was high (up to 81.2%). Participants with education of 6th to 12th class and those experiencing complications (pain abdomen, bleeding and discharge per vaginum) were more likely to remove the IUD with adjusted hazard ratio of 1.82 (95% CI: 1.18-2.79) and 4.39 (95% CI: 3.25-5.93) respectively. For expulsion, we did not find any factor that was statistically significant. CONCLUSION(S): PPIUD continuation rates declined considerably after the initial 6 weeks. Counselling and follow-up services for managing complications must be strengthened, especially in the first 6 weeks of PPIUD insertion, to enhance and sustain programmatic impact. IMPLICATIONS: Our findings emphasize on the need to strengthen client counseling and follow-up for management of complications, especially in the first 6 weeks of insertion of PPIUDs. Ongoing programs need to address comprehensive capacity building efforts in this regard.

Indexed as

Intrauterine DevicesPostpartum PeriodAdolescentAdultFamily Planning ServicesFemaleHumansIndiaProportional Hazards ModelsProspective StudiesYoung Adult

Identifiers

PMID38843221
PMCPMC11156399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.